I did read that part and will have to have another go over with regards to dosing levels. If that always happens regardless of the dosage we'll find out after the next testing is complete surely.
On a positive Transgene might have a new tg4010 partner by the end of the year and regardless will move into phase 3 trials, VHL's CR in March 2015 will only go towards fast tracking trials (and not into management's pockets) and ggti-2418 will start moving soon as well. I understand where you're coming from, if it's too risky then leave it be, but it's just the right amount of risk/reward to suck me in a little lol. I continue to hold but as always have no sentiment.
Cheers though, one of the best stock convos I've had for a while.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)